A gentler exam for increased patient comfort. FibroScan® is the first and only non-invasive device for diagnosis and monitoring of hepatic fibrosis.
Transient elastography makes it possible to measure the elasticity (stiffness) of tissue painlessly using ultrasound. This technology is unique to EchoSens S.A., which holds the exclusive rights for it. The adaptation of this technology to the liver has led to the development of the FibroScan® and its dedicated probes.
The device is composed of 3 key parts : a dedicated probe, an ultrasound system coupled to an elastometry system in the FibroScan® frame, and a specific software program that makes it possible to transcribe information obtained in the exam.
3-panel document
A gentler examination for increased patient comfort. FibroScan®, the first and only completely non-invasive device for diagnosis and monitoring of hepatic fibrosis.
Dedicated to the quantification of hepatic fibrosis, the FibroScan® has demonstrated, through numerous studies, its clinical utility and its superior reliability over biopsy and blood markers.
The clinical proofs
With more than 601 FibroScan® used worldwide, the scientific and medical community today unanimously recognises the progress afforded by this new device in the diagnosis of liver-related conditions. Extracts.
EXPERTISE